Home/Pipeline/Early Detection Test for Rheumatoid Arthritis

Early Detection Test for Rheumatoid Arthritis

Rheumatoid Arthritis

DevelopmentActive

Key Facts

Indication

Rheumatoid Arthritis

Phase

Development

Status

Active

Company

age-labs

About age-labs

Age Labs is a Norwegian life science company that develops diagnostic tests for early detection of age-related diseases using advanced machine learning on epigenetic datasets. Their pipeline includes a groundbreaking early detection test for rheumatoid arthritis, a biological age predictor, and COVID-19 severity prediction tests, alongside custom biomarker development services for pharmaceutical and nutraceutical industries.

View full company profile

Therapeutic Areas

Rheumatology Aging Infectious Diseases

Other Rheumatoid Arthritis Drugs

Drug	Company	Phase	Status
Piclidenoson (CF101)	can-fite-biopharma	Phase II/III	Previously Active
ERNA-201	eterna-therapeutics	Preclinical	Active Discovery/Research
Tc99m Tilmanocept	navidea-biopharmaceuticals	Phase 2/3	Jeopardized (Bankruptcy)
Monoclonal Antibody Biosimilar (Anti‑TNF)	usv-biologics-division	Phase 1	Active
Targeted Immunotherapy for Rheumatoid Arthritis (via Arthritis4Cure)	LFB	Pre-clinical	Development (Partnership)
EYD-001 (Takinib analog)	EydisBio	Preclinical	In vivo efficacy and pilot safety in progress
LFD-200	Lifordi Immunotherapeutics	Phase 1	Active
MEV-N01	mesenbio	Pre-clinical	Active